Exact Sciences Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures tepid as Middle East tensions keep investors wary
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Tesla to unveil Cybercab Texas today, details are few
- Snowflake soars 20% on earnings beat and raised guidance
- Oil prices hit fresh 6-week highs on renewed Middle East tensions
Exact Sciences (EXAS) PT Lowered to $38 at Canaccord Genuity After Selling 7M Shares
June 8, 2017 11:33 AM EDTCanaccord Genuity lowered its price target on Exact Sciences (NASDAQ: EXAS) to $38.00 (from $40.00) while maintaining a Buy rating. EXAS announced a raise of 7M shares of common stock at $35/share, to add $245M in gross proceeds and raise its cash balance to ~$500M.... More
